Ricki Louise Fairley's most recent trade in Xeris Biopharma Holdings Inc was a trade of 50,000 Common Stock done . Disclosure was reported to the exchange on June 5, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Xeris Biopharma Holdings Inc | Ricki Louise Fairley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 50,000 | 135,000 (0%) | 0% | 0 | Common Stock | |
Xeris Biopharma Holdings Inc | Ricki Louise Fairley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2023 | 85,000 | 85,000 (0%) | 0% | 0 | Common Stock |